Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 721 AL 735

Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit

Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B.

Ageing Res Rev. 2024 Aug;99:102348. doi: 10.1016/j.arr.2024.102348. Epub 2024 Jun 1.

Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy

Sai Varshini M, Aishwarya Reddy R, Thaggikuppe Krishnamurthy P.

J Drug Target. 2024 Sep;32(8):909-917. doi: 10.1080/1061186X.2024.2365263. Epub 2024 Jun 11.

Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges

Iqbal I, Saqib F, Mubarak Z, Latif MF, Wahid M, Nasir B, Shahzad H, Sharifi-Rad J, Mubarak MS.

Eur J Med Res. 2024 Jun 8;29(1):313. doi: 10.1186/s40001-024-01915-3.

The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease

Dong Q, Fu H, Jiang H.

Biomed Pharmacother. 2024 Jul;176:116880. doi: 10.1016/j.biopha.2024.116880. Epub 2024 Jun 7.

The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease

Balusu S, De Strooper B.

Acta Neuropathol. 2024 Jun 9;147(1):96. doi: 10.1007/s00401-024-02747-5.

Multi-target drugs for Alzheimer's disease

Turgutalp B, Kizil C.

Trends Pharmacol Sci. 2024 Jul;45(7):628-638. doi: 10.1016/j.tips.2024.05.005. Epub 2024 Jun 9.

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

Zeng L, Perin J, Gross AL, Shade D, Lanctôt KL, Lerner AJ, Mintzer JE, Brawman-Mintzer O, Padala PR, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Herrmann N, Rosenberg PB.

Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.

Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials

Chen X, Walton K, Brodaty H, Chalton K.

J Alzheimers Dis. 2024;101(s1):S479-S501. doi: 10.3233/JAD-231222.

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

Loeffler DA.

J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.

Gantenerumab for early Alzheimer's disease: a systematic review and meta-analysis

Menegaz de Almeida A, Leite M, Lopes LM, Gomes Lima P, Siegloch Barros ML, Rocha Pinheiro S, Andrade Í, Viana P, Morbach V, Marinheiro G, de Oliveira R, Pinheiro AC.

Expert Rev Neurother. 2024 Sep;24(9):929-936. doi: 10.1080/14737175.2024.2367016. Epub 2024 Jun 16.

Aggregation Mechanisms and Molecular Structures of Amyloid-β in Alzheimer's Disease

Niu Z, Gui X, Feng S, Reif B.

Chemistry. 2024 Aug 27;30(48):e202400277. doi: 10.1002/chem.202400277. Epub 2024 Aug 2.

A Comprehensive Analytical Review of Polyphenols: Evaluating Neuroprotection in Alzheimer's Disease

Vicente-Zurdo D, Gómez-Mejía E, Rosales-Conrado N, León-González ME.

Int J Mol Sci. 2024 May 28;25(11):5906. doi: 10.3390/ijms25115906.

Special Issue "Pathophysiology and Treatment of Alzheimer's Disease"

Fessel J.

Int J Mol Sci. 2024 May 30;25(11):6015. doi: 10.3390/ijms25116015.

CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review

Garemilla S, Kumari R, Kumar R.

Eur J Pharmacol. 2024 Sep 5;978:176760. doi: 10.1016/j.ejphar.2024.176760. Epub 2024 Jun 18.

Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements

Shastri D, Raj V, Lee S.

Ageing Res Rev. 2024 Aug;99:102379. doi: 10.1016/j.arr.2024.102379. Epub 2024 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias